AppLogic Networks Unveils 2025 Global Internet Phenomena Report: Key Insights into Internet Traffic Trends
Live sporting events drive new traffic peaks, while new encryption technologies complicate network management
AppLogic Networks (formerly Sandvine) is proud to announce the release of the 2025 Global Internet Phenomena Report (GIPR), an annual analysis that delivers in-depth insights into global internet traffic patterns and the applications driving that traffic.
Building on over a decade of research, this year's report utilizes the company’s innovative AppLogic product, allowing for unmatched coverage in identifying, categorizing, and measuring applications and application content across diverse networks worldwide. AppLogic employs machine learning and AI-powered analysis to accurately categorize applications, including encrypted traffic, ensuring a granular understanding of internet usage trends.
The GIPR's focus on application usage extends beyond overall traffic volume, providing a detailed examination of which applications are consuming the most bandwidth and potentially affecting network performance.
Key Topics in the 2025 Report Include:
- The Variable Nature of Application Popularity: While video remains the largest application category by volume, with users downloading an average 5.6GB per day, specific content types and applications are rapidly changing, highlighting the need for operators to adapt their strategies.
- The Rise of AI Assistants: Although AI assistants have not yet reached significant volume (only 7% of households in Fixed networks and 4% of mobile users), their rapidly growing popularity signals a potential future demand that operators must prepare for strategically. And, the tools of choice are evolving quickly, with variability seen across Gemini, Chat GPT, and Copilot across quarters in 2024.
- The Pervasiveness of Ad Analytics: Often regarded as "the most popular app no one knows about," advertising analytics are ubiquitous – with 93% of all Fixed network subscribers and 76% of all Mobile network subscribers – and their cumulative traffic must be closely monitored and optimized.
- The Evolution of Encryption Technologies: As encryption technologies advance, operators must invest in better classification methods to maintain service quality.
- The Game-Changing Impact of Live Streaming: The top ten traffic days in 2024 all coincided with a live streaming sporting event—either the NFL (#s 1-5, 7-10), or Netflix’s Paul vs. Tyson special (#6). Live sports events generate traffic peaks that can exceed normal usage by 30-40%, necessitating advanced planning by operators to manage these fluctuations without compromising user experience.
"In an increasingly dark internet age, service providers need to understand the applications that are driving internet usage and how to effectively manage their networks,” said Mark Driedger, CEO of AppLogic Networks. “Our data, in the GIPR and across our suite of software tools, empowers network operators to improve capacity planning, enhance service quality, and identify emerging market opportunities.”
“The GIPR presents a valuable resource for service providers, equipping them with the data necessary to optimize network capacity, address service quality challenges, and adapt to emerging trends,” continued Driedger. “By providing this report free to the industry, AppLogic Networks fosters an environment where service providers can better tailor their services to meet customer demands.”
To download a copy of AppLogic Networks’ 2025 Global Internet Phenomena Report, please visit AppLogic Networks website.
About AppLogic Networks
AppLogic Networks is on a mission to revolutionize network observability while serving as a champion of digital human rights. The company provides AI-powered application and network intelligence software solutions that help network operators analyze, optimize, and monetize their networks with contextual insights and real-time metrics—ultimately enabling the delivery of high-quality online experiences. AppLogic Networks is based in the US, with associates located in democracies around the globe.
For more information, please visit https://www.AppLogicNetworks.com/.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250303445046/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release
Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom